These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24592408)

  • 1. Effects of pioglitazone on insulin sensitivity and serum lipids in obese cats.
    Clark M; Thomaseth K; Dirikolu L; Ferguson DC; Hoenig M
    J Vet Intern Med; 2014; 28(1):166-74. PubMed ID: 24592408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of darglitazone on glucose clearance and lipid metabolism in obese cats.
    Hoenig M; Ferguson DC
    Am J Vet Res; 2003 Nov; 64(11):1409-13. PubMed ID: 14620778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of pioglitazone in lean and obese cats.
    Clark MH; Hoenig M; Ferguson DC; Dirikolu L
    J Vet Pharmacol Ther; 2012 Oct; 35(5):428-36. PubMed ID: 22612529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the sodium-glucose cotransporter 2 (SGLT2) inhibitor velagliflozin, a new drug with therapeutic potential to treat diabetes in cats.
    Hoenig M; Clark M; Schaeffer DJ; Reiche D
    J Vet Pharmacol Ther; 2018 Apr; 41(2):266-273. PubMed ID: 29139146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.
    Gastaldelli A; Harrison SA; Belfort-Aguilar R; Hardies LJ; Balas B; Schenker S; Cusi K
    Hepatology; 2009 Oct; 50(4):1087-93. PubMed ID: 19670459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II diabetes.
    Gastaldelli A; Casolaro A; Pettiti M; Nannipieri M; Ciociaro D; Frascerra S; Buzzigoli E; Baldi S; Mari A; Ferrannini E
    Clin Pharmacol Ther; 2007 Feb; 81(2):205-12. PubMed ID: 17259945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
    Miyazaki Y; Mahankali A; Wajcberg E; Bajaj M; Mandarino LJ; DeFronzo RA
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4312-9. PubMed ID: 15356026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways.
    Kubota N; Terauchi Y; Kubota T; Kumagai H; Itoh S; Satoh H; Yano W; Ogata H; Tokuyama K; Takamoto I; Mineyama T; Ishikawa M; Moroi M; Sugi K; Yamauchi T; Ueki K; Tobe K; Noda T; Nagai R; Kadowaki T
    J Biol Chem; 2006 Mar; 281(13):8748-55. PubMed ID: 16431926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes.
    Martens FM; Visseren FL; de Koning EJ; Rabelink TJ
    J Cardiovasc Pharmacol; 2005 Dec; 46(6):773-8. PubMed ID: 16306801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic Effects of Low-Dose Pioglitazone in Patients with the Metabolic Syndrome without Diabetes Mellitus.
    Vu A; Kosmiski LA; Beitelshees AL; Prigeon R; Sidhom MS; Bredbeck B; Predhomme J; Deininger KM; Aquilante CL
    Pharmacotherapy; 2016 Mar; 36(3):252-62. PubMed ID: 26822630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOW.
    Tripathy D; Clement SC; Schwenke DC; Banerji M; Bray GA; Buchanan TA; Gastaldelli A; Henry RR; Kitabchi AE; Mudaliar S; Ratner RE; Stentz FB; Musi N; Reaven PD; DeFronzo RA
    Diabetes Care; 2014 Jun; 37(6):1706-11. PubMed ID: 24705615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
    Miyazaki Y; DeFronzo RA
    Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
    Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
    Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and sex influence insulin resistance and total and multimer adiponectin levels in adult neutered domestic shorthair client-owned cats.
    Bjornvad CR; Rand JS; Tan HY; Jensen KS; Rose FJ; Armstrong PJ; Whitehead JP
    Domest Anim Endocrinol; 2014 Apr; 47():55-64. PubMed ID: 24373250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of obesity on lipid profiles in neutered male and female cats.
    Hoenig M; Wilkins C; Holson JC; Ferguson DC
    Am J Vet Res; 2003 Mar; 64(3):299-303. PubMed ID: 12661869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of omega-3 fatty acids on serum concentrations of adipokines in healthy cats.
    Mazaki-Tovi M; Abood SK; Schenck PA
    Am J Vet Res; 2011 Sep; 72(9):1259-65. PubMed ID: 21879986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic treatment with pioglitazone does not protect obese patients with diabetes mellitus type II from free fatty acid-induced insulin resistance.
    Serlie MJ; Allick G; Groener JE; Ackermans MT; Heijligenberg R; Voermans BC; Aerts JM; Meijer AJ; Sauerwein HP
    J Clin Endocrinol Metab; 2007 Jan; 92(1):166-71. PubMed ID: 17062758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ameliorations of pioglitazone on insulin resistance in spontaneous IGT-OLETF rats].
    Ding SY; Shen ZF; Chen YT; Xie MZ
    Yao Xue Xue Bao; 2004 Jul; 39(7):514-7. PubMed ID: 15493839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study.
    Tripathy D; Daniele G; Fiorentino TV; Perez-Cadena Z; Chavez-Velasquez A; Kamath S; Fanti P; Jenkinson C; Andreozzi F; Federici M; Gastaldelli A; Defronzo RA; Folli F
    Diabetologia; 2013 Oct; 56(10):2153-63. PubMed ID: 23811853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys.
    Kemnitz JW; Elson DF; Roecker EB; Baum ST; Bergman RN; Meglasson MD
    Diabetes; 1994 Feb; 43(2):204-11. PubMed ID: 8288044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.